Previous Pause Next
Home >> News Center >> Products & Services >>
Products & Services
Vermillion Announces Issuance Of Patent For Peripheral Artery Disease PDF Print E-mail
Tuesday, 18 January 2011 20:01

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company. The patent claims are directed to Beta-2 microglobulin and biomarker combinations that include Beta-2 microglobulin for the diagnosis and management of peripheral artery disease and to the measurement of the biomarkers by a variety of methods, including mass spectrometry and immunoassay.

Read more...
 
Sensipar(R) Patents Upheld By District Court PDF Print E-mail
Tuesday, 18 January 2011 00:13

A U.S. District Court in Delaware today granted an injunction preventing Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries Ltd., and Barr Laboratories, Inc. from commercializing generic versions of Amgen's (Nasdaq: AMGN) Sensipar(R) (cinacalcet) until expiration of the drug's U.S. patents. The latest Sensipar expiry is in 2018. Sensipar is approved for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis and for the treatment of elevated levels of calcium in patients with parathyroid carcinoma.

Read more...
 
Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent PDF Print E-mail
Tuesday, 11 January 2011 07:03

Optimer Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,863,249 which covers additional dosage forms of fidaxomicin. This patent further strengthens Optimer's patent protection for fidaxomicin. The newly issued patent and a previously issued patent encompassing fidaxomicin are both orange book listable.

Read more...
 
DyLight ® conjugated Fluorescent Rabbit Monoclonal Antibodies PDF Print E-mail
Tuesday, 04 January 2011 22:06

DyLight Fluorescent Dyes - High Intensity, Photostable

DyLight conjugated RabMAbs ® provides the combined benefits of Epitomics Rabbit Monoclonal technology and highly functional DyLight fluorphores together for a high performance primary antibodies ideal for demanding Immunofluorescent and Flow Cytometry applications.

Read more...
 
Omni Bio Pharmaceutical Awarded Patent For Preventing Anthrax Infection PDF Print E-mail
Tuesday, 04 January 2011 21:33

Omni Bio Pharmaceutical, Inc. ("Omni Bio") , today announced that U.S. Patent No. 7,850,970, entitled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections," was issued by the United States Patent and Trademark Office (USPTO) on December 14, 2010 (the "New Patent").

 

Read more...
 
Synergy H1 Hybrid Multi-Mode Microplate Reader PDF Print E-mail
Monday, 03 January 2011 22:13

Synergy™ H1 is a flexible monochromator-based multi-mode microplate reader that can be turned into a high-performance hybrid system with the addition of a filter-based optical module. The monochromator optics uses a third generation quadruple grating design that allows working at any excitation or emission wavelength with a 1 nm step. This system supports top and bottom fluorescence intensity, UV-visible absorbance and high performance luminescence detection.

Read more...
 
Eppendorf Eporator® PDF Print E-mail
Monday, 03 January 2011 06:26

Welcome the Eppendorf Eporator®, the solution for efficiently transforming bacteria and yeast! The Eppendorf Eporator is the perfect fit for you and your lab. Ask the specialists – your bacteria and yeast – they will confirm that the product features and performance of the Eppendorf Eporator make it very easy for you to carry out your experiments and obtain excellent results.

Read more...
 
AMV Reverse Transcriptase PDF Print E-mail
Friday, 31 December 2010 04:01

AMV Reverse Transcriptase (Standard Grade) synthesizes cDNA from single stranded RNA. The standard concentration is 20 units/µL and the specific activity is 40,000-50,000 units per mg.

Read more...
 
The Eco™ Real-Time PCR System from Illumina® PDF Print E-mail
Friday, 31 December 2010 03:38

The Eco™ Real-Time PCR System from Illumina® delivers high-performance qPCR at an accessible price. The full-featured Eco performs even the most demanding qPCR applications, including SNP and methylation detection by HRM. The system is calibrated for SYBR, FAM, HEX, VIC, ROX, and Cy5 binding dyes and offers the fastest block-based cycling available. It supports all commonly used chemistries and provides four-color multiplexing.

Read more...
 
Mithras Microplate Reader LB 940 PDF Print E-mail
Thursday, 30 December 2010 01:23

Multi-technology Microplate Reader with exceptional sensitivity
Mithras is a multi-technology reader for a wide range of microplate formats and up to 9 different reading technologies.

Read more...
 
Ascension Orthopedics Granted Patent For PyroCarbon Humeral Head Design PDF Print E-mail
Tuesday, 18 January 2011 00:16

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the receipt of a European patent for a PyroCarbon humeral head design currently being developed as a component of the TITAN? Modular Shoulder System released in September 2010.

 

Read more...
 
BioDrain Medical, Inc. Is Eligible For Trading On The OTCBB, Notice Of Allowance On Canadian Patent Application PDF Print E-mail
Tuesday, 11 January 2011 19:42

BioDrain Medical, Inc. , producer of the FDA cleared Streamway? system for automated surgical fluid disposal, announced today it is eligible for trading on the Over The Counter Bulletin Board (OTCBB).


The company was admitted to the OTCBB early in 2010 but lost this eligibility as a result of their OTCBB market maker going out of business. For the last several months the stock has continued to trade on the OTC Pink Markets, in the OTCQB segment, and will continue to trade in the OTC Pink Markets as well as the OTCBB.

Read more...
 
.Omni Bio Pharmaceutical Awarded Patent For Preventing Anthrax Infection PDF Print E-mail
Thursday, 06 January 2011 20:36

Omni Bio Pharmaceutical, Inc. ("Omni Bio") , today announced that U.S. Patent No. 7,850,970, entitled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections," was issued by the United States Patent and Trademark Office (USPTO) on December 14, 2010 (the "New Patent").

 

Read more...
 
OrbusNeich Granted Expanded U.S. Patent Of Genous? Endothelial Progenitor Cell Capture Technology PDF Print E-mail
Tuesday, 04 January 2011 21:35

OrbusNeich today announced that the United States Patent and Trademark Office (USPTO) has granted an additional patent expanding protection of the company's Genous endothelial progenitor cell (EPC) capture technology.


The patent (U.S. Pat. No. US 7,803,183) covers a coating on an implantable medical device that has one or more layers of a matrix. Incorporated into the matrix are antibodies or antibody fragments that allow for capture in vivo of circulating EPCs.

 

Read more...
 
Ion Channel and Transporter-specific Antibodies PDF Print E-mail
Monday, 03 January 2011 22:15

Ion channels and transporters are a relatively unexplored drug target class and have not been as functionally interrogated like the G-protein coupled receptors (GPCRs). Ion Channel therapeutic areas include congenital, central nervous system, skeletal muscle, and kidney disorders, pain, and more. Importantly, ion channels research has resulted in numerous successful drugs, indicating it to be a successful field for drug candidates.

Read more...
 
New Second Edition Of Biotechnology And The Federal Circuit Examines The Court's Decisions On Chemical, Biotechnology, And Pharmaceutical Patent Law Cases PDF Print E-mail
Monday, 03 January 2011 22:09

BNA Books, a division of BNA, announces the publication of theSecond Edition of Biotechnology and the Federal Circuit, the only reference work that provides an in-depth consideration of the entire body of Federal Circuit precedent in the rapidly developing area of biotechnology.

Read more...
 
Rabbit Anti-Human ATM Monoclonal Antibody, DyLight 488 Conjugated PDF Print E-mail
Monday, 03 January 2011 06:23

DyLight conjugated RabMAbs® provides the combined benefits of Epitomics Rabbit Monoclonal technology and highly functional DyLight fluorphores together for a high performance primary antibodies–ideal for demanding Immunofluorescent and Flow Cytometry applications.

Read more...
 
CB 53 CO2 incubator with O2 Control PDF Print E-mail
Friday, 31 December 2010 03:43

CB Series of High-Performance Tissue Culture Incubators with O2 Control

  • Patented APT.Line air jacket system assures temperature accuracy and reproducible results
  • Patented Permadry system keeps chamber walls and door dry at a humidity of 95%
  • FDA compliant 180 degrees C hot air sterilization using an overnight cycle time
Read more...
 
Whole Genome Sequencing PDF Print E-mail
Thursday, 30 December 2010 01:25

We offer Whole Genome Sequencing and Next-Generation Sequencing services in conjunction with Macrogen Inc. in South Korea. As a leader in the sequencing service world, Macrogen USA Corp. adapts to cutting-edge technologies and utilizes invaluable experiences from Macrogen, Inc. (Korea).

Read more...
 
ProteoExtract™ Complete Mammalian Proteome Extraction Kit PDF Print E-mail
Thursday, 30 December 2010 01:21

A kit designed to extract virtually all proteins from both mammalian tissue culture cells and tissues in two steps within a microcentrifuge tube to minimize protein loss.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 13